Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells
Authors:
- 1 July 2015
- journal article
- Published by Elsevier in Cardiovascular Pathology
- Vol. 24 (4) , 230-235
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Dihydrocapsaicin Attenuates Plaque Formation through a PPARγ/LXRα Pathway in apoE−/− Mice Fed a High-Fat/High-Cholesterol DietPLOS ONE, 2013
- Effects of Propofol, a Sedative-Hypnotic Drug, on the Lipid Profile, Antioxidant Indices, and Cardiovascular Marker Enzymes in Wistar RatsISRN Pharmacology, 2013
- Drug‐administration sequence of target‐controlled propofol and remifentanil influences the onset of rocuronium. A double‐blind, randomized trialActa Anaesthesiologica Scandinavica, 2012
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- PPARγ activation redirects macrophage cholesterol from fecal excretion to adipose tissue uptake in mice via SR-BIBiochemical Pharmacology, 2011
- Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune ResponsesArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- PPARγ1 and LXRα face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1Nuclear Receptor Signaling, 2010
- Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion developmentFEBS Letters, 2006
- Reverse cholesterol transport and cholesterol efflux in atherosclerosisQJM: An International Journal of Medicine, 2005
- Specificity and Properties of Propofol as an Antioxidant Free Radical ScavengerToxicology and Applied Pharmacology, 1994